Multiple dysregulated signaling pathways are implicated in the pathogenesis of cancer. The
conventional therapies used in cancer prevention/treatment suffer from low efficacy …

Lichens have been concerned by many researchers because of their unique secondary
metabolites. However, the research on edible lichens is still lacking. This review collected …

Lichens produce different classes of phenolic compounds, including anthraquinones,
xanthones, dibenzofuranes, depsides and depsidones. Many of them have revealed …

As an important source of drugs, natural products play an important role in the discovery and
development of new drugs. More than 60% of anti-tumor drugs are closely related to natural …

T cells expressing chimeric antigen receptors, especially CD19 CAR-T cells have exhibited
effective antitumor activities in B cell malignancies, but due to several factors such as …

Depsidones are some of the most abundant secondary metabolites produced by lichens.
These compounds have aroused great pharmacological interest due to their activities as …

Lichens are symbiotic organisms composed of at least one fungal and one algal species.
They are found in different environments around the world, even in the poles and deserts …

Triple‐negative breast cancer (TNBC) makes up 15% to 20% of all breast cancer (BC)
cases, and represents one of the most challenging malignancies to treat. For many years …

Hepatocellular carcinoma (HCC), a primary malignancy of the liver, is a threat to the health
of all humans as a prevalent malignancy and is the sixth most common cancer worldwide. It …

Lichen-forming fungi are symbiotic organisms that synthesize unique natural products with
potential for new drug leads. Here, we explored the pharmacological activity of six lichen …